Analyst Ratings for Banco Macro S.A. ADR (BMA)

Updated: 2017-07-27

Banco Macro S.A. ADR (NYSE:BMA) was awarded an average rating of Overweight from investment analysts following the stock. Last month, BMA received an average rating of Overweight.

5 analysts declared BMA a buy, 0 gave an overweight rating, 6 issued a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Several price targets were given for BMA by the analysts covering the stock. The most optimistic price target was 142.46, which equates to a potential upside of 61.78 percent. The lowest price target was 85.16, which equates to a potential downside of -3.29 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -1.84 percent. The average change in earnings estimates over the last 90 days is 0.03 percent. Meanwhile, fiscal year estimates have been revised downwards by -0.62 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 0.2 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 2 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 2 analysts that revised their FY estimates downwards.

BMA has an estimated earnings growth rate of 10.14 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of BMA is 1.11.

In the last 52-weeks, BMA has achieved a high of 97.86 and a low of 61.12. Today's price is 44.08 percent above the 52-week low, and 10.01 percent lower than its 52-week high. BMA has a price/earnings ratio of 11.3. Investors typically compare the P/E ratio to a company's peers in the industry. The BMA value stock report compares BMA to some of its peers using value stock charts. The stock has a market capitalization of $5.91 billion. BMA will post this quarters earnings in days, on 0000-00-00.